Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

计划入组 12 人 · 首次发布于 2005 年 8 月 30 日

Endometriosis and Complement System

计划入组 58 人 · 首次发布于 2024 年 7 月 10 日

Genetic Polymorphisms of Mannan-binding Lectin (MBL)and Serum Levels of MBL in Patients With Endometriosis

计划入组 100 人 · 首次发布于 2012 年 11 月 30 日

OMS906

mannan Binding Lectin associated serine protease 2 inhibitor(Helion Biotech ApS)

mannose binding lectin

Associated Capital

United States

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

FDA Grants Rare Pediatric Disease Designation to Omeros' Zaltenibart for C3 Glomerulopathy

Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy